BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced on 5/24/18 that BioMarin received standard approval from the U.S. Food and Drug Administration (FDA) for Palynziq (pegvaliase-pqpz) Injection... read more
BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced on 5/24/18 that BioMarin received standard approval from the U.S. Food and Drug Administration (FDA) for Palynziq (pegvaliase-pqpz) Injection... read more
Bicycle Therapeutics, announced on 5/24/18 that it is expanding its collaboration with AstraZeneca to include additional targets in respiratory and cardio-metabolic diseases.
The original... read more
Brii Bio announced on 5/24/18 its launch with significant partnerships and financing. Brii Bio aims to accelerate the development and delivery of breakthrough medicines in China through... read more
The test, which is at the proof-of-concept stage, can rapidly screen a drop of blood for biomarkers of pancreatic cancer. It can provide results in less than an hour. The findings were published... read more
